3.85%C 7.22 11.94%GE 17.61 13.61%
The Global Business News Leader | Tuesday, 2 Dec 2008
- EQUITY MARKETS
- BONDS AND RATES
- FOREX
- COMMODITIES
- LANGUAGES
- FUNDS
- RETIREMENT
- TAXES
- INSURANCE
- INVESTING
- LANGUAGES
- MOVIE
- MUSIC
- TV
- CELEBRITIES
- LANGUAGES
PONIARD PHARMAECUTICALS INC.
PARD (NASDAQ)
$ 2.90 
Change: 0 0% | Volume: 18,619
Change: 0 0% | Volume: 18,619
Sponsored by 
PONIARD PHARMAC - Fundamental Profile
Company Information
| Ticker Symbol: | PARD |
|---|---|
| Exchange: | NASD |
| Contact Info: | 7000 Shoreline Court South San Francisco CA 94080 650 583-3774 |
| CEO/President: | Gerald McMahon Ph.D. |
| Industry: | Medical - Drugs / Standard Industry Code: 2835 |
| Description: | Poniard Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the discovery, development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company\'s lead product candidate, is a new generation platinum therapy that provides a differentiated spectrum of activity and an improved safety profile. An intravenous chemotherapeutic agent, picoplatin is designed to overcome platinum resistance associated with the treatment of solid tumors. Picoplatin currently is being studied in clinical trials for the treatment of small cell lung, colorectal and hormone-refractory prostate cancers. As part of the Company\'s strategic goal of building a diverse oncology pipeline, the Company also is collaborating with the Scripps Florida Research Institute on the discovery of novel, small-molecule, multi-targeted protein kinase inhibitors. |
Share Information
| Shares Outstanding: | 34,690 (000) | Market Value: | 103,020 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 46.75% | Number of Inst.Shareholders: | 40.50% |
| Last Quarter Sales: | 0.00 ($Mil.) | Last Quarter Net Income: | -12.53 ($Mil.) |
| Last Quarter EPS: | -0.36 | P/E Ratio: | 0 |
| Most Recent Earnings: | Earnings Per Share: | -1.13 | |
| Most Recent Split: | 1-6 on 09/25/06 | Annual Dividend Rate: | 0 |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
Top Competitors
| PFIZER INC |  |
-26.60 | 16.43 |
| JOHNSON AND JOH | |
-14.40 | 58.58 |
| BRISTOL MYERS S | |
-21.50 | 20.70 |
| SCHERING PLOUGH | |
-38.30 | 16.81 |
| MERCK CO INC | |
-53.90 | 26.72 |
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives